EC: 1.1.1.62
17beta-estradiol 17-dehydrogenase (17beta-estradiol:NAD(P)+ 17-oxidoreductase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY-7455 | allopregnanolone biosynthesis |
| BioCyc:HUMAN_ILEUDEG-PWY | isoleucine degradation |
| BioCyc:HUMAN_PWY66-378 | androgen biosynthesis |
| BioCyc:META_PWY66-380 | estradiol biosynthesis I (via estrone) |
| BioCyc:META_FAO-PWY | fatty acid β-oxidation I |
| BioCyc:META_ILEUDEG-PWY | L-isoleucine degradation I |
| BioCyc:META_PWY-6074 | zymosterol biosynthesis |
| BioCyc:MOUSE_PWY66-3 | cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:HUMAN_PWY66-5 | superpathway of cholesterol biosynthesis |
| BioCyc:HUMAN_PWY66-341 | cholesterol biosynthesis I |
| BioCyc:META_PWY66-341 | cholesterol biosynthesis I |
| BioCyc:META_PWY66-4 | cholesterol biosynthesis III (via desmosterol) |
| BioCyc:MOUSE_PWY3DJ-0 | isoleucine degradation |
| BioCyc:MOUSE_PWY66-341 | cholesterol biosynthesis I |
| BioCyc:HUMAN_PWY66-3 | cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:HUMAN_PWY-6074 | zymosterol biosynthesis |
| BioCyc:HUMAN_PWY66-380 | estradiol biosynthesis I |
| BioCyc:META_PWY66-378 | androgen biosynthesis |
| BioCyc:META_PWY66-3 | cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:MOUSE_PWY-5109 | 2-methylbutyrate biosynthesis |
| BioCyc:HUMAN_PWY66-4 | cholesterol biosynthesis III (via desmosterol) |
| BioCyc:HUMAN_FAO-PWY | fatty acid β-oxidation |
| BioCyc:META_PWY-7455 | allopregnanolone biosynthesis |
| BioCyc:META_PWY66-5 | superpathway of cholesterol biosynthesis |
| BioCyc:MOUSE_FAO-PWY | fatty acid β-oxidation I |
| BioCyc:MOUSE_PWY66-4 | cholesterol biosynthesis III (via desmosterol) |
| BioCyc:MOUSE_PWY-5136 | fatty acid β-oxidation II (core pathway) |
| Reactome:R-HSA-9757110 | Prednisone ADME |
| Reactome:R-HSA-9748784 | Drug ADME |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-71291 | Amino acid and derivative metabolism |
| Reactome:R-CFA-1430728 | Metabolism |
| Reactome:R-CFA-556833 | Metabolism of lipids |
| Reactome:R-CFA-75105 | Fatty acyl-CoA biosynthesis |
| Reactome:R-HSA-75105 | Fatty acyl-CoA biosynthesis |
| Reactome:R-HSA-6807047 | Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-HSA-70895 | Branched-chain amino acid catabolism |
| Reactome:R-HSA-5362517 | Signaling by Retinoic Acid |
| Reactome:R-HSA-72306 | tRNA processing |
| Reactome:R-HSA-6785470 | tRNA processing in the mitochondrion |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-556833 | Metabolism of lipids |
| Reactome:R-MMU-75105 | Fatty acyl-CoA biosynthesis |
| Reactome:R-MMU-8957322 | Metabolism of steroids |
| Reactome:R-MMU-193144 | Estrogen biosynthesis |
| Reactome:R-MMU-70895 | Branched-chain amino acid catabolism |
| Reactome:R-RNO-8978868 | Fatty acid metabolism |
| Reactome:R-RNO-6807062 | Zymostenol biosynthesis via lathosterol (Kandutsch-Russell pathway) |
| Reactome:R-RNO-196071 | Metabolism of steroid hormones |
| Reactome:R-RNO-70895 | Branched-chain amino acid catabolism |
| Reactome:R-BTA-70895 | Branched-chain amino acid catabolism |
| Reactome:R-CFA-8978868 | Fatty acid metabolism |
| Reactome:R-DME-1430728 | Metabolism |
| Reactome:R-DME-71291 | Amino acid and derivative metabolism |
| Reactome:R-HSA-556833 | Metabolism of lipids |
| Reactome:R-HSA-8978868 | Fatty acid metabolism |
| Reactome:R-HSA-2162123 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |
| Reactome:R-HSA-191273 | Cholesterol biosynthesis |
| Reactome:R-HSA-193144 | Estrogen biosynthesis |
| Reactome:R-HSA-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-MMU-8978868 | Fatty acid metabolism |
| Reactome:R-MMU-6807062 | Zymostenol biosynthesis via lathosterol (Kandutsch-Russell pathway) |
| Reactome:R-MMU-196071 | Metabolism of steroid hormones |
| Reactome:R-RNO-8964572 | Lipid particle organization |
| Reactome:R-RNO-6807047 | Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-HSA-6807062 | Zymostenol biosynthesis via lathosterol (Kandutsch-Russell pathway) |
| Reactome:R-HSA-71291 | Amino acid and derivative metabolism |
| Reactome:R-HSA-5365859 | RA biosynthesis pathway |
| Reactome:R-HSA-8953854 | Metabolism of RNA |
| Reactome:R-HSA-6787450 | tRNA modification in the mitochondrion |
| Reactome:R-MMU-191273 | Cholesterol biosynthesis |
| Reactome:R-MMU-71291 | Amino acid and derivative metabolism |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-556833 | Metabolism of lipids |
| Reactome:R-RNO-75105 | Fatty acyl-CoA biosynthesis |
| Reactome:R-RNO-8957322 | Metabolism of steroids |
| Reactome:R-RNO-193144 | Estrogen biosynthesis |
| Reactome:R-RNO-71291 | Amino acid and derivative metabolism |
| Reactome:R-DME-70895 | Branched-chain amino acid catabolism |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-8964572 | Lipid particle organization |
| Reactome:R-HSA-2142753 | Arachidonate metabolism |
| Reactome:R-HSA-8957322 | Metabolism of steroids |
| Reactome:R-HSA-196071 | Metabolism of steroid hormones |
| Reactome:R-HSA-162582 | Signaling Pathways |
| Reactome:R-HSA-72312 | rRNA processing |
| Reactome:R-HSA-8868766 | rRNA processing in the mitochondrion |
| Reactome:R-MMU-8964572 | Lipid particle organization |
| Reactome:R-MMU-6807047 | Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-RNO-191273 | Cholesterol biosynthesis |
| WikiPathways:WP5287 | 17q12 copy number variation syndrome |
| WikiPathways:WP5280 | Glucocorticoid biosynthesis |
| WikiPathways:WP5368 | Sulfatase and aromatase pathway |
| WikiPathways:WP5320 | Male steroid hormones in cardiomyocyte energy metabolism |
| WikiPathways:WP5176 | Disorders of bile acid synthesis and biliary transport |
| WikiPathways:WP4686 | Leucine, isoleucine and valine metabolism |
| WikiPathways:WP4524 | Alternative pathway of fetal androgen synthesis |
| PathBank:SMP0120658 | 17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0120794 | Mevalonic Aciduria |
| PathBank:SMP0030406 | Androstenedione Metabolism |
| PathBank:SMP0120440 | 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency |
| PathBank:SMP0120444 | 3-Methylglutaconic Aciduria Type IV |
| PathBank:SMP0120516 | Maple Syrup Urine Disease |
| PathBank:SMP0120589 | Isovaleric Acidemia |
| PathBank:SMP0120629 | Aromatase Deficiency |
| PathBank:SMP0121057 | Bloch Pathway (Cholesterol Biosynthesis) |
| PathBank:SMP0000032 | Valine, Leucine, and Isoleucine Degradation |
| PathBank:SMP0000023 | Steroid Biosynthesis |
| PathBank:SMP0000068 | Androgen and Estrogen Metabolism |
| PathBank:SMP0000173 | beta-Ketothiolase Deficiency |
| PathBank:SMP0000199 | Maple Syrup Urine Disease |
| PathBank:SMP0000384 | Methylmalonate Semialdehyde Dehydrogenase Deficiency |
| PathBank:SMP0000387 | CHILD Syndrome |
| PathBank:SMP0000083 | Acetylsalicylic Acid Action Pathway |
| PathBank:SMP0000087 | Rofecoxib Action Pathway |
| PathBank:SMP0000094 | Sulindac Action Pathway |
| PathBank:SMP0000373 | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0000318 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0000141 | 3-Methylglutaconic Aciduria Type IV |
| PathBank:SMP0000104 | Indomethacin Action Pathway |
| PathBank:SMP0000120 | Naproxen Action Pathway |
| PathBank:SMP0000112 | Risedronate Action Pathway |
| PathBank:SMP0000106 | Meloxicam Action Pathway |
| PathBank:SMP0000508 | Cholesteryl Ester Storage Disease |
| PathBank:SMP0000524 | Isovaleric Acidemia |
| PathBank:SMP0000544 | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) |
| PathBank:SMP0000568 | Short-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (SCHAD) |
| PathBank:SMP0000576 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000693 | Antrafenine Action Pathway |
| PathBank:SMP0000697 | Flurbiprofen Action Pathway |
| PathBank:SMP0000701 | Phenylbutazone Action Pathway |
| PathBank:SMP0000705 | Tiaprofenic Acid Action Pathway |
| PathBank:SMP0000709 | Salicylic Acid Action Pathway |
| PathBank:SMP0000718 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0087326 | Steroid Biosynthesis |
| PathBank:SMP0063612 | Fatty Acid Elongation In Mitochondria |
| PathBank:SMP0120685 | Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2) |
| PathBank:SMP0120769 | Hypercholesterolemia |
| PathBank:SMP0120793 | Hyper-IgD Syndrome |
| PathBank:SMP0120439 | 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency |
| PathBank:SMP0120443 | 3-Methylglutaconic Aciduria Type III |
| PathBank:SMP0120459 | beta-Ketothiolase Deficiency |
| PathBank:SMP0120503 | Isovaleric Aciduria |
| PathBank:SMP0120523 | Methylmalonate Semialdehyde Dehydrogenase Deficiency |
| PathBank:SMP0120588 | Isobutyryl-CoA Dehydrogenase Deficiency |
| PathBank:SMP0120608 | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) |
| PathBank:SMP0120632 | Short-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (SCHAD) |
| PathBank:SMP0000054 | Fatty Acid Elongation in Mitochondria |
| PathBank:SMP0000035 | Bile Acid Biosynthesis |
| PathBank:SMP0000075 | Arachidonic Acid Metabolism |
| PathBank:SMP0000356 | 17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0000138 | 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency |
| PathBank:SMP0000140 | 3-Methylglutaconic Aciduria Type III |
| PathBank:SMP0000238 | Isovaleric Aciduria |
| PathBank:SMP0000389 | Smith-Lemli-Opitz Syndrome (SLOS) |
| PathBank:SMP0000319 | Lysosomal Acid Lipase Deficiency (Wolman Disease) |
| PathBank:SMP0000082 | Simvastatin Action Pathway |
| PathBank:SMP0000086 | Ibuprofen Action Pathway |
| PathBank:SMP0000093 | Diclofenac Action Pathway |
| PathBank:SMP0000098 | Ketorolac Action Pathway |
| PathBank:SMP0000314 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0000315 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0000102 | Bromfenac Action Pathway |
| PathBank:SMP0000114 | Nabumetone Action Pathway |
| PathBank:SMP0000111 | Cerivastatin Action Pathway |
| PathBank:SMP0000131 | Atorvastatin Action Pathway |
| PathBank:SMP0000511 | Wolman Disease |
| PathBank:SMP0000523 | Isobutyryl-CoA Dehydrogenase Deficiency |
| PathBank:SMP0000575 | 11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000692 | Antipyrine Action Pathway |
| PathBank:SMP0000696 | Fenoprofen Action Pathway |
| PathBank:SMP0000700 | Lornoxicam Action Pathway |
| PathBank:SMP0000704 | Tolmetin Action Pathway |
| PathBank:SMP0000708 | Salicylate-Sodium Action Pathway |
| PathBank:SMP0000717 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0087353 | Retinol Metabolism |
| PathBank:SMP0087365 | Estrone Metabolism |
| PathBank:SMP0063641 | Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids |
| PathBank:SMP0063689 | Valine, Leucine, and Isoleucine Degradation |
| PathBank:SMP0120684 | CHILD Syndrome |
| PathBank:SMP0120692 | Desmosterolosis |
| PathBank:SMP0120720 | Vitamin A Deficiency |
| PathBank:SMP0120732 | Lysosomal Acid Lipase Deficiency (Wolman Disease) |
| PathBank:SMP0120792 | Cholesteryl Ester Storage Disease |
| PathBank:SMP0120848 | Aromatase Deficiency |
| PathBank:SMP0120437 | 17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0120441 | 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I |
| PathBank:SMP0120525 | Methylmalonic Aciduria |
| PathBank:SMP0120537 | Propionic Acidemia |
| PathBank:SMP0120586 | 3-Hydroxyisobutyric Acid Dehydrogenase Deficiency |
| PathBank:SMP0121060 | Kandutsch-Russell Pathway (Cholesterol Biosynthesis) |
| PathBank:SMP0000130 | Steroidogenesis |
| PathBank:SMP0000137 | 2-Methyl-3-hydroxybutyryl-CoA Dehydrogenase Deficiency |
| PathBank:SMP0000237 | 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I |
| PathBank:SMP0000200 | Methylmalonic Aciduria |
| PathBank:SMP0000386 | Desmosterolosis |
| PathBank:SMP0000077 | Piroxicam Action Pathway |
| PathBank:SMP0000084 | Etodolac Action Pathway |
| PathBank:SMP0000089 | Pravastatin Action Pathway |
| PathBank:SMP0000095 | Alendronate Action Pathway |
| PathBank:SMP0000371 | Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0000317 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0000109 | Mefenamic Acid Action Pathway |
| PathBank:SMP0000289 | Diflunisal Action Pathway |
| PathBank:SMP0000099 | Lovastatin Action Pathway |
| PathBank:SMP0000117 | Pamidronate Action Pathway |
| PathBank:SMP0000116 | Valdecoxib Action Pathway |
| PathBank:SMP0000509 | Hyper-IgD Syndrome |
| PathBank:SMP0000521 | 3-Hydroxyisobutyric Acid Dehydrogenase Deficiency |
| PathBank:SMP0000565 | Aromatase Deficiency |
| PathBank:SMP0000577 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0000650 | Doxorubicin Metabolism Pathway |
| PathBank:SMP0000694 | Carprofen Action Pathway |
| PathBank:SMP0000698 | Magnesium Salicylate Action Pathway |
| PathBank:SMP0000702 | Nepafenac Action Pathway |
| PathBank:SMP0000706 | Tenoxicam Action Pathway |
| PathBank:SMP0000710 | Acetaminophen Action Pathway |
| PathBank:SMP0087260 | Retinol Metabolism |
| PathBank:SMP0087344 | Androgen and Estrogen Metabolism |
| PathBank:SMP0087364 | Androstenedione Metabolism |
| PathBank:SMP0063594 | Androgen and Estrogen Metabolism |
| PathBank:SMP0120735 | Smith-Lemli-Opitz Syndrome (SLOS) |
| PathBank:SMP0120795 | Wolman Disease |
| PathBank:SMP0030880 | Estrone Metabolism |
| PathBank:SMP0120442 | 3-Methylglutaconic Aciduria Type I |
| PathBank:SMP0120587 | 3-Hydroxyisobutyric Aciduria |
| PathBank:SMP0000236 | Propionic Acidemia |
| PathBank:SMP0000139 | 3-Methylglutaconic Aciduria Type I |
| PathBank:SMP0000388 | Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2) |
| PathBank:SMP0000353 | Leukotriene C4 Synthesis Deficiency |
| PathBank:SMP0000079 | Ibandronate Action Pathway |
| PathBank:SMP0000085 | Ketoprofen Action Pathway |
| PathBank:SMP0000092 | Rosuvastatin Action Pathway |
| PathBank:SMP0000096 | Celecoxib Action Pathway |
| PathBank:SMP0000480 | Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids |
| PathBank:SMP0000372 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0000316 | Zellweger Syndrome |
| PathBank:SMP0000209 | Hypercholesterolemia |
| PathBank:SMP0000101 | Suprofen Action Pathway |
| PathBank:SMP0000113 | Oxaprozin Action Pathway |
| PathBank:SMP0000107 | Zoledronate Action Pathway |
| PathBank:SMP0000119 | Fluvastatin Action Pathway |
| PathBank:SMP0000510 | Mevalonic Aciduria |
| PathBank:SMP0000522 | 3-Hydroxyisobutyric Aciduria |
| PathBank:SMP0000566 | 17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0000578 | Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0000635 | Valproic Acid Metabolism Pathway |
| PathBank:SMP0000695 | Etoricoxib Action Pathway |
| PathBank:SMP0000699 | Lumiracoxib Action Pathway |
| PathBank:SMP0000703 | Trisalicylate-Choline Action Pathway |
| PathBank:SMP0000707 | Salsalate Action Pathway |
| PathBank:SMP0000720 | 27-Hydroxylase Deficiency |
| PathBank:SMP0087251 | Androgen and Estrogen Metabolism |
| PathBank:SMP0087271 | Androstenedione Metabolism |
| PathBank:SMP0063696 | Estrone Metabolism |